Cargando…

COVID-19 and systemic lupus erythematosus: a case series

Detalles Bibliográficos
Autores principales:	Gartshteyn, Yevgeniya, Askanase, Anca D, Schmidt, Nancyanne M, Bernstein, Elana J, Khalili, Leila, Drolet, Rachel, Broderick, Rachel J, Geraldino-Pardilla, Laura, Kapoor, Teja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250558/ https://www.ncbi.nlm.nih.gov/pubmed/32835249 http://dx.doi.org/10.1016/S2665-9913(20)30161-2

Ejemplares similares

Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
por: Kapoor, Teja, et al.
Publicado: (2020)

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis
por: Geraldino-Pardilla, Laura, et al.
Publicado: (2016)

Prevalence of coronary artery calcification in young patients with SLE of predominantly Hispanic and African–American descent
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2019)

Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography
por: Perel-Winkler, Alexandra, et al.
Publicado: (2018)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients
por: Park, Elizabeth, et al.
Publicado: (2021)

Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
por: Park, Elizabeth, et al.
Publicado: (2021)

The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data
por: Tang, Wei, et al.
Publicado: (2021)

Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020)

The Use of COVID-19 Vaccines in Patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
por: Izmirly, Peter, et al.
Publicado: (2019)

SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2021)

Lupus clinical trials and the promise of future therapies
por: Khalili, Leila, et al.
Publicado: (2023)

The Impact of Telemedicine on Rheumatology Care
por: Tang, Wei, et al.
Publicado: (2022)

Evaluation of SLE arthritis using frequency domain optical imaging
por: Marone, Alessandro, et al.
Publicado: (2021)

A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2022)

SLAMF6 compartmentalization enhances T cell functions
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2022)

Treatment Satisfaction in Systemic Lupus Erythematosus: Development of a Patient-Reported Outcome Measure
por: Mathias, Susan D., et al.
Publicado: (2017)

Telerheumatology: A Narrative Review
por: Tang, Wei, et al.
Publicado: (2021)

Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
por: DeMizio, Daniel J., et al.
Publicado: (2019)

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
por: Thanou, Aikaterini, et al.
Publicado: (2019)

Thoughts on COVID-19 and autoimmune diseases
por: Askanase, Anca D, et al.
Publicado: (2020)

Low‐Density Neutrophils in Systemic Lupus Erythematosus
por: Tay, Sen Hee, et al.
Publicado: (2020)

Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Askanase, Anca D., et al.
Publicado: (2020)

Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.
por: Li, Xiao, et al.
Publicado: (2016)

Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Askanase, Anca D., et al.
Publicado: (2021)

Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment
por: Mathias, Susan D., et al.
Publicado: (2017)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation
por: Hassanalilou, Tohid, et al.
Publicado: (2017)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
por: Fernandez-Ruiz, Ruth, et al.
Publicado: (2020)

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
por: Celhar, Teja, et al.
Publicado: (2014)

Modelling clinical systemic lupus erythematosus: similarities, differences and success stories
por: Celhar, Teja, et al.
Publicado: (2017)

Pathways leading to an immunological disease: systemic lupus erythematosus
por: Zharkova, Olga, et al.
Publicado: (2017)

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series
por: Keyes, Emily, et al.
Publicado: (2021)

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
por: van Vollenhoven, Ronald, et al.
Publicado: (2022)

Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey
por: Birt, Julie A., et al.
Publicado: (2021)

Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)

Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021)

Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(®) Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)

Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
por: Mathias, S. D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_016pqnnmfbde60vqasj8vn7jic